# IRON SUCROSE
> **ANDA212559** · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN LABS LTD · Approved 2025-08-08
## Drug
- **FDA Application Number:** ANDA212559
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** IRON SUCROSE
- **Generic name:** IRON SUCROSE
- **Active ingredients:** IRON SUCROSE
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** MYLAN LABS LTD
- **Manufacturer:** Mylan Institutional LLC
- **First approval:** 2025-08-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212559)
---
*AI Analytics · CC0 1.0*